CanSino Biologics Inc.

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

33.59%

Market Cap

-

P/E Ratio

256.14

Dividend Yield

0.00 %

Earnings per Share

0.01 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE2.42 G0 Units
PRICE DETERMINATION TIME06/19/2026 / 09:55:56 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW2.442.42
PREV. DAY'S PRICE2.42 (06/18)
CHANGE DAY BEFORE
+0.00
0.00 %
52 WEEK HIGH / LOW5.94 (09/15)2.4 (06/17)
More Price Information

Key Figures (in EUR)

2027e2026e202520242023
EARNINGS PER SHARE0.110.040.01-0.20-0.78
DIVIDENDS PER SHARE0.000.000.000.000.00
DIVIDEND YIELD IN %--0.00 %0.00 %0.00 %
DIVIDEND GROWTH IN %-----
PRICE - EARNINGS RATIO23.6760.61256.14--
PRICE - BOOK RATIO--1.401.400.91
PRICE - SALES RATIO--6.748.1713.84
PRICE - CASH FLOW RATIO--214.11--
Further Key Figures

Master Data

WKN
A2PGFW
ISIN
CNE100003F01
SYMBOL
CJH
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
CANSINO BIOLOGICS H YC 1
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
-
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
-
MARKET CAPITALISATION
-

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
-3.97 %
-23.42 %
-34.24 %
-39.65 %
-33.59 %
-26.24 %
-93.62 %
-35.54 %
HIGH2.463.143.804.265.945.9445.654.26
LOW2.402.402.402.402.401.801.802.40
Dividend
per share
CANSINO BIOLOGICS H YC 1 does not deliver dividend information

Company profile

CanSino Biologics, Inc. engages in the research and development, manufacturing, and sale of vaccines. It offers shingles, meningitis, polio, adenovirus, and tuberculosis vaccines. The company was founded by Xuan Liu, Xue Feng Yu, Tao Zhu, Dong Xu Qiu and Hui Hua Mao on January 13, 2009 and is headquartered in Tianjin, China.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.